OTC Firms Try Again For Benzocaine Monograph Status
This article was originally published in The Tan Sheet
Executive Summary
Labels for benzocaine-containing oral analgesics would include pictograms in the Drug Facts box to show consumers how much product to use, under a proposal by the Consumer Healthcare Products Association
You may also be interested in...
Benzocaine Monograph For Toothache Requires Further Study – FDA
FDA says benzocaine-containing oral analgesic manufacturers will have to conduct a larger clinical trial to support a Category I (safe and effective) classification for the treatment of toothaches
Benzocaine Dose-Response Seen Strongest In Severe Toothache Pain – CHPA
The dose-response relationship of 10% and 20% strengths of benzocaine is particularly significant for patients with severe toothache pain, data forwarded to FDA by the Consumer Healthcare Products Association suggests
Del, Whitehall benzocaine studies lack reliable toothache relief duration data, FDA says.
DEL, WHITEHALL BENZOCAINE STUDIES LACK RELIABLE RELIEF DURATION DATA on toothache pain, FDA concludes in a July 17 "feedback" letter to the Nonprescription Drug Manufacturers Association. In a review of three efficacy studies submitted by Whitehall-Robins on benzocaine as a toothache relief agent and five efficacy trials by Del Pharmaceuticals, FDA states: "The frequency of dosing cannot be predictably determined from these data, especially due to the fact that duration of relief in the studies submitted did not appear to be dose-related."